Stem Cells International

Mesenchymal Stem Cell Therapy in Nonhematopoietic Diseases


Publishing date
15 Aug 2014
Status
Published
Submission deadline
28 Mar 2014

1Stem Cell Research Laboratory, Pequeno Príncipe Faculty & The Pelé Pequeno Príncipe Institute of Child and Adolescent Health Research, Curitiba, PR, Brazil

2Cardiac Bioassist Unit, Pompidou Hospital, Laboratory of Biosurgical Research, Carpentier Foundation, University of Paris, Paris, France

3Department of Cardiac Surgery, Medical Faculty University of Rostock, Rostock, Germany


Mesenchymal Stem Cell Therapy in Nonhematopoietic Diseases

Description

Extensive clinical experiences with stem cells, particularly for the treatment of hematological diseases, have suggested the use of stem cells to treat nonhematopoietic diseases. Mesenchymal stem cells (MSCs) have shown promise for regeneration and repair of many tissues. Due to their presence in all organs, their easy isolation, as well as their pluripotency, MSCs are considered an important focus of current and future cell therapies for regenerative medicine.

In this issue, we invite authors to discuss the potential use of MSCs for (1) tissue regeneration in nonhematopoietic diseases, (2) development of preclinical and clinical models for nonhematopoietic diseases, and (3) study of their intrinsic properties: molecular, cellular, immunological, and differentiation capabilities. We invite submission of papers. Potential topics include, but are not limited to:

  • Solid organ cancer
  • Cardiomyopathy
  • Neurodegenerative disease
  • Neuromuscular disease
  • Stroke
  • Spinal cord and brain trauma
  • Skin disease and wound healing
  • Bone disease
  • Tissue engineering
  • Bioartificial organs

Before submission authors should carefully read over the journal’s Author Guidelines, which are located at http://www.hindawi.com/journals/sci/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/sci/mesen/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2015
  • - Article ID 676903
  • - Editorial

Mesenchymal Stem Cell Therapy in Nonhematopoietic Diseases

Katherine Athayde Teixeira de Carvalho | Gustav Steinhoff | Juan Carlos Chachques
  • Special Issue
  • - Volume 2015
  • - Article ID 146051
  • - Research Article

Human Adult Stem Cells Maintain a Constant Phenotype Profile Irrespective of Their Origin, Basal Media, and Long Term Cultures

Indumathi Somasundaram | Rashmi Mishra | ... | Dhanasekaran Marappagounder
  • Special Issue
  • - Volume 2014
  • - Article ID 340257
  • - Review Article

Management of Fibrosis: The Mesenchymal Stromal Cells Breakthrough

Benoît Usunier | Marc Benderitter | ... | Alain Chapel
  • Special Issue
  • - Volume 2014
  • - Article ID 939674
  • - Research Article

The Efficacy of Mesenchymal Stem Cell Transplantation in Caustic Esophagus Injury: An Experimental Study

Murat Kantarcioglu | Bahadir Caliskan | ... | Sait Bagci
  • Special Issue
  • - Volume 2014
  • - Article ID 276862
  • - Research Article

Enhanced Adipogenicity of Bone Marrow Mesenchymal Stem Cells in Aplastic Anemia

Naresh Kumar Tripathy | Saurabh Pratap Singh | Soniya Nityanand
  • Special Issue
  • - Volume 2014
  • - Article ID 306573
  • - Review Article

Clinical Applications of Mesenchymal Stem Cells in Chronic Diseases

Andrea Farini | Clementina Sitzia | ... | Yvan Torrente
  • Special Issue
  • - Volume 2014
  • - Article ID 197154
  • - Research Article

Magnetic Nanoparticle Based Nonviral MicroRNA Delivery into Freshly Isolated CD105+ hMSCs

Anna Schade | Paula Müller | ... | Robert David
Stem Cells International
 Journal metrics
Acceptance rate45%
Submission to final decision76 days
Acceptance to publication35 days
CiteScore3.800
Impact Factor3.902
 Submit

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.